Visnagin Inhibitor

Visnagin has acute hypotensive, anti-inflammatory, and neuroprotective effects, it protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase.

Radim Vrzal, et al. Khellin and Visnagin Differentially Modulate AHR Signaling and Downstream CYP1A Activity in Human Liver Cells. PLoS One. 2013 Sep 19;8(9):e74917.
Radim Vrzal, et al. Khellin and Visnagin Differentially Modulate AHR Signaling and Downstream CYP1A Activity in Human Liver Cells. PLoS One. 2013 Sep 19;8(9):e74917.
Min-Soo Kwon, et al. Neuroprotective Effect of Visnagin on Kainic Acid-induced Neuronal Cell Death in the Mice Hippocampus.
Min-Soo Kwon, et al. Neuroprotective Effect of Visnagin on Kainic Acid-induced Neuronal Cell Death in the Mice Hippocampus. Korean J Physiol Pharmacol. 2010 Oct;14(5):257-63.
J Duarte, et al. Cardiovascular Effects of Visnagin on Rats. Planta Med. 2000 Feb;66(1):35-9.
J Duarte, et al. Cardiovascular Effects of Visnagin on Rats. Planta Med. 2000 Feb;66(1):35-9.

Small volumes of Visnagin, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5759019 is an inhibitor targeting Visnagin.